189.76 USD
↗ 1.64 (0.87%)AT CLOSE (03:59 PM EDT)
Revolution Medicines, Inc. Common Stock
RVMDNASDAQ • USD
189.48
↘ 0.28 (0.15%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
189.48
↘ 0.28 (0.15%)
Market: CLOSED
RVMD is currently priced at $189.76. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, RVMD is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 9, 2026.
Open?$186.01
High?$193.50
Low?$184.37
Prev. Close?$188.12
Volume?2.2M
Avg. Volume?2.1M
VWAP?$189.41
Rel. Volume?1.06x
Bid / Ask
Bid?$180.31 × 100
Ask?$199.16 × 100
Spread?$18.85
Midpoint?$189.74
Valuation & Ratios
Market Cap?40.3B
Shares Out?214.3M
Float?194.4M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?15.47
EPS?-$8.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Employees
883
Market Cap
40.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-02-13
Address
700 SAGINAW DR
REDWOOD CITY, CA 94063
Phone: 650-481-6801
REDWOOD CITY, CA 94063
Phone: 650-481-6801
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?42
Piotroski F-Score?0/9Weak
Altman Z-Score?12.58Safe
Confidence?55%Low
Short InterestElevated
Short % of Float?6.13%Elevated
Short Interest?11.9M
Days to Cover?4.7
Free Float194.4M
Avg Daily Volume2.6M
Settlement Date2026-09-30
Financial Health
Current Ratio?11.38Strong
Quick Ratio?11.38Strong
Cash Ratio?2.30Strong
Debt/Equity?0.19Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?15.47HIGH▾
Peers100
S&P11
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-24.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-67.9%WEAK▾
S&P3
ROA?-40.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-1232131000
Enterprise Value?$40.0B
Fundamentals ratios updated end of day